Literature DB >> 30558447

The prodrug approach in the era of drug design.

Anas Najjar1, Rafik Karaman1.   

Abstract

Keywords:  Baloxavir marboxil; FDA approved; drug design; fosnetupitant; latanoprostene bunod; prodrugs; strategies; success; tafenoquine

Year:  2018        PMID： 30558447     DOI： 10.1080/17425247.2019.1553954

Source DB:  PubMed          Journal:  Expert Opin Drug Deliv        ISSN： 1742-5247            Impact factor:   6.648


× No keyword cloud information.
  10 in total

Review 1.  A Historical Review of Brain Drug Delivery.

Authors:  William M Pardridge
Journal:  Pharmaceutics       Date:  2022-06-16       Impact factor: 6.525

Review 2.  Structural Modification in Anesthetic Drug Development for Prodrugs and Soft Drugs.

Authors:  Chaoyi Deng; Jin Liu; Wensheng Zhang
Journal:  Front Pharmacol       Date:  2022-07-01       Impact factor: 5.988

Review 3.  Phosphonates and Phosphonate Prodrugs in Medicinal Chemistry: Past Successes and Future Prospects.

Authors:  Marcela Krečmerová; Pavel Majer; Rana Rais; Barbara S Slusher
Journal:  Front Chem       Date:  2022-05-20       Impact factor: 5.545

Review 4.  Computational Simulations to Guide Enzyme-Mediated Prodrug Activation.

Authors:  Milica Markovic; Shimon Ben-Shabat; Arik Dahan
Journal:  Int J Mol Sci       Date:  2020-05-20       Impact factor: 5.923

5.  Molecularly Imprinted Polymer-Based Smart Prodrug Delivery System for Specific Targeting, Prolonged Retention, and Tumor Microenvironment-Triggered Release.

Authors:  Zikuan Gu; Yueru Dong; Shuxin Xu; Lisheng Wang; Zhen Liu
Journal:  Angew Chem Int Ed Engl       Date:  2020-12-03       Impact factor: 15.336

Review 6.  Molecular imprinting of glycoproteins: From preparation to cancer theranostics.

Authors:  Muhammad Mujahid Ali; Shoujun Zhu; Farrukh Raza Amin; Dilshad Hussain; Zhenxia Du; Lianghai Hu
Journal:  Theranostics       Date:  2022-02-28       Impact factor: 11.556

7.  A biocompatible poly(amidoamine) (PAMAM) dendrimer octa-substituted with α-cyclodextrin towards the controlled release of doxorubicin hydrochloride from its ferrocenyl prodrug.

Authors:  Artur Kasprzak; Bartłomiej Dabrowski; Agnieszka Zuchowska
Journal:  RSC Adv       Date:  2020-06-19       Impact factor: 4.036

Review 8.  Antibacterial Prodrugs to Overcome Bacterial Resistance.

Authors:  Buthaina Jubeh; Zeinab Breijyeh; Rafik Karaman
Journal:  Molecules       Date:  2020-03-28       Impact factor: 4.411

9.  Effects of Genetic Polymorphisms of Cathepsin A on Metabolism of Tenofovir Alafenamide.

Authors:  Soichiro Ito; Takeshi Hirota; Miyu Yanai; Mai Muto; Eri Watanabe; Yuki Taya; Ichiro Ieiri
Journal:  Genes (Basel)       Date:  2021-12-20       Impact factor: 4.096

Review 10.  Prodrug Therapies for Infectious and Neurodegenerative Diseases.

Authors:  Milica Markovic; Suyash Deodhar; Jatin Machhi; Pravin Yeapuri; Maamoon Saleh; Benson J Edagwa; Rodney Lee Mosley; Howard E Gendelman
Journal:  Pharmaceutics       Date:  2022-02-26       Impact factor: 6.525
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.